{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:55:27Z","timestamp":1787237727253,"version":"build-2736575974"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T00:00:00Z","timestamp":1672617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003789","name":"Helwan University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003789","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Microbiol"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Infectious diseases remain one of the major health challenges worldwide due to the problem of antimicrobial resistance. Conventional antimicrobials have the disadvantage that bacteria rapidly acquire resistance to them, so alternatives must be developed to combat antibiotic resistance. Nanotechnology and the repurposing of existing drugs with known biological profiles are new approaches to replacing conventional antimicrobials. In this paper, we have tested the antibacterial activity of sodium acetate (NaA), vitamin C (VC), and zinc oxide nanoparticles (ZnO NPs) against\n                    <jats:italic>Escherichia coli<\/jats:italic>\n                    O157:H7 ATCC 51659 and\n                    <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                    ATCC 27853\n                    <jats:italic>.<\/jats:italic>\n                    MIC values for tested compounds ranged from 0.08 to 6.5\u00a0mg\u00a0ml\n                    <jats:sup>\u22121<\/jats:sup>\n                    , and the effect of combinations and safety profiles against HepG2 cell line of these compounds were also evaluated. At sub-MIC values, tested compounds had a potential antivirulence effect by inhibiting motility and reducing biofilm formation and maturation. Collectively, ZnO NPs and VC are considered safe alternatives to traditional antibiotics that are capable of reducing the development of antibiotic resistance in microbes.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Graphical Abstract<\/jats:bold>\n                  <\/jats:p>\n                  <jats:p>\n                    Graphical abstract representing the main aim and the final findings of our work. Spread of multidrug-resistant (MDR) bacterial strains created an urge for alternative safe antimicrobial agents. In this work, we found that ZnO NPs and vitamin C are potential candidates that could be used against MDR\n                    <jats:italic>E.coli<\/jats:italic>\n                    and\n                    <jats:italic>P. aeruginosa<\/jats:italic>\n                    .\n                  <\/jats:p>","DOI":"10.1007\/s00284-022-03151-6","type":"journal-article","created":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T21:02:23Z","timestamp":1672606943000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Antibacterial and Antivirulence Activities of Acetate, Zinc Oxide Nanoparticles, and Vitamin C Against E. coli O157:H7 and P. aeruginosa"],"prefix":"10.1007","volume":"80","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9508-8049","authenticated-orcid":false,"given":"Selwan","family":"Hamed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Emara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,2]]},"reference":[{"issue":"4","key":"3151_CR1","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1177\/10600280211031390","volume":"56","author":"EB Chahine","year":"2022","unstructured":"Chahine EB et al (2022) Antibiotic approvals in the last decade: are we keeping up with resistance? Ann Pharmacother 56(4):441\u2013462. https:\/\/doi.org\/10.1177\/10600280211031390","journal-title":"Ann Pharmacother"},{"key":"3151_CR2","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.nmni.2015.02.007","volume":"6","author":"I Roca","year":"2015","unstructured":"Roca I et al (2015) The global threat of antimicrobial resistance: science for intervention. New Microbes New Infect 6:22\u201329. https:\/\/doi.org\/10.1016\/j.nmni.2015.02.007","journal-title":"New Microbes New Infect"},{"issue":"1","key":"3151_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13756-022-01078-y","volume":"11","author":"S Lakoh","year":"2022","unstructured":"Lakoh S et al (2022) Incidence and risk factors of surgical site infections and related antibiotic resistance in Freetown, Sierra Leone: a prospective cohort study. Antimicrob Resist Infect Control 11(1):39. https:\/\/doi.org\/10.1186\/s13756-022-01078-y","journal-title":"Antimicrob Resist Infect Control"},{"issue":"12","key":"3151_CR4","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00925-21","volume":"65","author":"MC Kelly","year":"2021","unstructured":"Kelly MC et al (2021) Incidence and predictors of gram-negative bacilli in hospitalized people who inject drugs with injection drug use-attributable infections. Antimicrob Agents Chemother 65(12):e0092521. https:\/\/doi.org\/10.1128\/AAC.00925-21","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"3151_CR5","doi-asserted-by":"publisher","first-page":"e354","DOI":"10.1016\/S2666-5247(21)00090-2","volume":"2","author":"CD Russell","year":"2021","unstructured":"Russell CD et al (2021) Co-infections, secondary infections, and antimicrobial use in patients hospitalised with COVID-19 during the first pandemic wave from the ISARIC WHO CCP-UK study: a multicentre, prospective cohort study. Lancet Microbe 2(8):e354\u2013e365. https:\/\/doi.org\/10.1016\/S2666-5247(21)00090-2","journal-title":"Lancet Microbe"},{"issue":"1","key":"3151_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12866-017-0964-z","volume":"17","author":"AF Beyi","year":"2017","unstructured":"Beyi AF et al (2017) Prevalence and antimicrobial susceptibility of Escherichia coli O157 in beef at butcher shops and restaurants in central Ethiopia. BMC Microbiol 17(1):49. https:\/\/doi.org\/10.1186\/s12866-017-0964-z","journal-title":"BMC Microbiol"},{"key":"3151_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25215024","author":"F Guzzo","year":"2020","unstructured":"Guzzo F et al (2020) Plant derived natural products against Pseudomonas aeruginosa and staphylococcus aureus: antibiofilm activity and molecular mechanisms. Molecules. https:\/\/doi.org\/10.3390\/molecules25215024","journal-title":"Molecules"},{"key":"3151_CR8","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01296-18","author":"F D'Angelo","year":"2018","unstructured":"D\u2019Angelo F et al (2018) Identification of FDA-approved drugs as antivirulence agents targeting the pqs quorum-sensing system of Pseudomonas aeruginosa. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.01296-18","journal-title":"Antimicrob Agents Chemother"},{"issue":"16","key":"3151_CR9","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1021\/acs.orglett.0c02403","volume":"22","author":"S Zhao","year":"2020","unstructured":"Zhao S et al (2020) Synthesis of Vitamin B12-antibiotic conjugates with greatly improved activity against gram-negative bacteria. Org Lett 22(16):6632\u20136636. https:\/\/doi.org\/10.1021\/acs.orglett.0c02403","journal-title":"Org Lett"},{"issue":"5","key":"3151_CR10","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/cmdc.202000792","volume":"16","author":"G Viault","year":"2021","unstructured":"Viault G et al (2021) Semisynthetic vitamin e derivatives as potent antibacterial agents against resistant gram-positive pathogens. ChemMedChem 16(5):881\u2013890. https:\/\/doi.org\/10.1002\/cmdc.202000792","journal-title":"ChemMedChem"},{"issue":"8","key":"3151_CR11","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1007\/s00284-020-01991-8","volume":"77","author":"SM Gad El-Rab","year":"2020","unstructured":"Gad El-Rab SM, Abo-Amer AE, Asiri AM (2020) Biogenic synthesis of ZnO nanoparticles and its potential use as antimicrobial agent against multidrug-resistant pathogens. Curr Microbiol 77(8):1767\u20131779","journal-title":"Curr Microbiol"},{"issue":"9","key":"3151_CR12","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1021\/acsomega.1c07209","volume":"7","author":"AS Eltaweil","year":"2022","unstructured":"Eltaweil AS et al (2022) Novel biogenic synthesis of a Ag@ Biochar nanocomposite as an antimicrobial agent and photocatalyst for methylene blue degradation. ACS Omega 7(9):8046\u20138059","journal-title":"ACS Omega"},{"issue":"12","key":"3151_CR13","first-page":"1","volume":"2","author":"S Hamed","year":"2015","unstructured":"Hamed S et al (2015) N-acetyl cysteine substantially enhances the antimicrobial activity of zinc oxide nanoparticles against multidrug resistant pathogens. Int J Adv Res Biol Sci 2(12):1\u201315","journal-title":"Int J Adv Res Biol Sci"},{"issue":"39","key":"3151_CR14","doi-asserted-by":"publisher","first-page":"25397","DOI":"10.1021\/acsomega.1c03355","volume":"6","author":"AM Abdelfatah","year":"2021","unstructured":"Abdelfatah AM et al (2021) Green synthesis of nano-zero-valent iron using ricinus communis seeds extract: characterization and application in the treatment of methylene blue-polluted water. ACS Omega 6(39):25397\u201325411","journal-title":"ACS Omega"},{"issue":"2","key":"3151_CR15","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.ijantimicag.2016.11.011","volume":"49","author":"A Raghunath","year":"2017","unstructured":"Raghunath A, Perumal E (2017) Metal oxide nanoparticles as antimicrobial agents: a promise for the future. Int J Antimicrob Agents 49(2):137\u2013152. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.11.011","journal-title":"Int J Antimicrob Agents"},{"issue":"2","key":"3151_CR16","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3390\/nano10020292","volume":"10","author":"E S\u00e1nchez-L\u00f3pez","year":"2020","unstructured":"S\u00e1nchez-L\u00f3pez E et al (2020) Metal-Based nanoparticles as antimicrobial agents: an overview. Nanomaterials 10(2):292","journal-title":"Nanomaterials"},{"key":"3151_CR17","doi-asserted-by":"publisher","DOI":"10.1590\/1519-6984.247165","volume":"83","author":"S Mumtaz","year":"2021","unstructured":"Mumtaz S et al (2021) Evaluation of antibacterial activity of vitamin C against human bacterial pathogens. Braz J Biol 83:e247165. https:\/\/doi.org\/10.1590\/1519-6984.247165","journal-title":"Braz J Biol"},{"issue":"3","key":"3151_CR18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1556\/1886.2019.00016","volume":"9","author":"S Mousavi","year":"2019","unstructured":"Mousavi S, Bereswill S, Heimesaat MM (2019) Immunomodulatory and Antimicrobial Effects of Vitamin C. Eur J Microbiol Immunol (Bp) 9(3):73\u201379. https:\/\/doi.org\/10.1556\/1886.2019.00016","journal-title":"Eur J Microbiol Immunol (Bp)"},{"key":"3151_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1016\/j.ijbiomac.2020.11.174","volume":"168","author":"M Doostan","year":"2021","unstructured":"Doostan M et al (2021) Effective antibacterial electrospun cellulose acetate nanofibrous patches containing chitosan\/erythromycin nanoparticles. Int J Biol Macromol 168:464\u2013473. https:\/\/doi.org\/10.1016\/j.ijbiomac.2020.11.174","journal-title":"Int J Biol Macromol"},{"issue":"3","key":"3151_CR20","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","volume":"18","author":"E Tacconelli","year":"2018","unstructured":"Tacconelli E et al (2018) Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis 18(3):318\u2013327. https:\/\/doi.org\/10.1016\/S1473-3099(17)30753-3","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"3151_CR21","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/s1369-5274(00)00242-3","volume":"4","author":"K Poole","year":"2001","unstructured":"Poole K (2001) Multidrug resistance in Gram-negative bacteria. Curr Opin Microbiol 4(5):500\u2013508. https:\/\/doi.org\/10.1016\/s1369-5274(00)00242-3","journal-title":"Curr Opin Microbiol"},{"key":"3151_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics8020037","author":"EM Eichenberger","year":"2019","unstructured":"Eichenberger EM, Thaden JT (2019) Epidemiology and mechanisms of resistance of extensively drug resistant gram-negative bacteria. Antibiotics (Basel). https:\/\/doi.org\/10.3390\/antibiotics8020037","journal-title":"Antibiotics (Basel)"},{"issue":"3","key":"3151_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1089\/mdr.2018.0380","volume":"25","author":"HO Khalifa","year":"2019","unstructured":"Khalifa HO et al (2019) High Prevalence of antimicrobial resistance in gram-negative bacteria isolated from clinical settings in Egypt: recalling for judicious use of conventional antimicrobials in developing nations. Microb Drug Resist 25(3):371\u2013385. https:\/\/doi.org\/10.1089\/mdr.2018.0380","journal-title":"Microb Drug Resist"},{"issue":"12","key":"3151_CR24","first-page":"45","volume":"2","author":"S Hamed","year":"2015","unstructured":"Hamed S et al (2015) N-acetyl cysteine substantially enhances the antimicrobial activity of zinc oxidenanoparticles against multidrug resistant pathogens. Int J Adv Res Biol Sci 2(12):45\u201349","journal-title":"Int J Adv Res Biol Sci"},{"issue":"1","key":"3151_CR25","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s42506-018-0006-1","volume":"94","author":"MSM Nassar","year":"2019","unstructured":"Nassar MSM, Hazzah WA, Bakr WMK (2019) Evaluation of antibiotic susceptibility test results: how guilty a laboratory could be? J Egypt Public Health Assoc 94(1):4. https:\/\/doi.org\/10.1186\/s42506-018-0006-1","journal-title":"J Egypt Public Health Assoc"},{"key":"3151_CR26","unstructured":"CLSI (2015) Clinical and Laboratory Standards Institute\u00a011 edition M07\u00a0(Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically).\u00a0\u00a0https:\/\/clsi.org\/media\/1928\/m07ed11_sample.pdf"},{"key":"3151_CR27","doi-asserted-by":"publisher","DOI":"10.3791\/53028","author":"LM Koeth","year":"2015","unstructured":"Koeth LM, DiFranco-Fisher Jeanna M, McCurdy.S, (2015) A reference Broth microdilution method for dalbavancin in vitro susceptibility testing of bacteria that grow aerobically. JoVE. https:\/\/doi.org\/10.3791\/53028","journal-title":"JoVE"},{"key":"3151_CR28","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00271-19","author":"Y Zhang","year":"2019","unstructured":"Zhang Y et al (2019) Synergistic Effect of colistin combined with PFK-158 against colistin-Resistant Enterobacteriaceae. Antimicrob Agents Chemother. https:\/\/doi.org\/10.1128\/AAC.00271-19","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"3151_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jac\/dkg301","volume":"52","author":"FC Odds","year":"2003","unstructured":"Odds FC (2003) Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 52(1):1. https:\/\/doi.org\/10.1093\/jac\/dkg301","journal-title":"J Antimicrob Chemother"},{"key":"3151_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103927","volume":"140","author":"D Bhattacharya","year":"2020","unstructured":"Bhattacharya D et al (2020) Anti-virulence activity of polyphenolic fraction isolated from kombucha against Vibrio cholerae. Microb Pathog 140:103927. https:\/\/doi.org\/10.1016\/j.micpath.2019.103927","journal-title":"Microb Pathog"},{"key":"3151_CR31","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13756-019-0637-9","volume":"8","author":"S Samarasinghe","year":"2019","unstructured":"Samarasinghe S, Reid R, Al-Bayati M (2019) The anti-virulence effect of cranberry active compound proanthocyanins (PACs) on expression of genes in the third-generation cephalosporin-resistant Escherichia coli CTX-M-15 associated with urinary tract infection. Antimicrob Resist Infect Control 8:181. https:\/\/doi.org\/10.1186\/s13756-019-0637-9","journal-title":"Antimicrob Resist Infect Control"},{"key":"3151_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-0473-0_7","volume":"1149","author":"DG Ha","year":"2014","unstructured":"Ha DG, Kuchma SL, O\u2019Toole GA (2014) Plate-based assay for swimming motility in Pseudomonas aeruginosa. Methods Mol Biol 1149:59\u201365. https:\/\/doi.org\/10.1007\/978-1-4939-0473-0_7","journal-title":"Methods Mol Biol"},{"key":"3151_CR33","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ecoenv.2018.12.096","volume":"171","author":"P Chen","year":"2019","unstructured":"Chen P et al (2019) Size-dependent cytotoxicity study of ZnO nanoparticles in HepG2 cells. Ecotoxicol Environ Saf 171:337\u2013346. https:\/\/doi.org\/10.1016\/j.ecoenv.2018.12.096","journal-title":"Ecotoxicol Environ Saf"},{"issue":"11","key":"3151_CR34","doi-asserted-by":"publisher","first-page":"4671","DOI":"10.7314\/apjcp.2015.16.11.4671","volume":"16","author":"EA Elsayed","year":"2015","unstructured":"Elsayed EA, Sharaf-Eldin MA, Wadaan M (2015) In vitro evaluation of cytotoxic activities of essential oil from moringa oleifera seeds on HeLa, HepG2, MCF-7, CACO-2 and L929 Cell Lines. Asian Pac J Cancer Prev 16(11):4671\u20134675. https:\/\/doi.org\/10.7314\/apjcp.2015.16.11.4671","journal-title":"Asian Pac J Cancer Prev"},{"issue":"2","key":"3151_CR35","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1177\/08968608211045272","volume":"42","author":"H Wu","year":"2022","unstructured":"Wu H et al (2022) Changes of antibiotic resistance over time among Escherichia coli peritonitis in Southern China. Perit Dial Int 42(2):218\u2013222. https:\/\/doi.org\/10.1177\/08968608211045272","journal-title":"Perit Dial Int"},{"issue":"5","key":"3151_CR36","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1017\/ice.2019.64","volume":"40","author":"JN Kubes","year":"2019","unstructured":"Kubes JN, Fridkin SK (2019) Factors affecting the geographic variability of antibiotic-resistant healthcare-associated infections in the United States using the CDC antibiotic resistance patient safety Atlas. Infect Control Hosp Epidemiol 40(5):597\u2013599. https:\/\/doi.org\/10.1017\/ice.2019.64","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"3151_CR37","first-page":"12","volume":"10","author":"Hamed.S,","year":"2017","unstructured":"Hamed.S, et al (2017) N-acetylcysteine potentiates the antimicrobial activity of gold nanoparticles a paradigm shift in treatment of multidrug resistant pathogens. EC Microbiology 10(3):12","journal-title":"EC Microbiology"},{"issue":"1","key":"3151_CR38","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.ram.2016.11.011","volume":"50","author":"J Cabezas-Pizarro","year":"2018","unstructured":"Cabezas-Pizarro J et al (2018) Antimicrobial activity of different sodium and potassium salts of carboxylic acid against some common foodborne pathogens and spoilage-associated bacteria. Rev Argent Microbiol 50(1):56\u201361. https:\/\/doi.org\/10.1016\/j.ram.2016.11.011","journal-title":"Rev Argent Microbiol"},{"key":"3151_CR39","doi-asserted-by":"publisher","DOI":"10.3390\/ma14144051","author":"K Hurtukova","year":"2021","unstructured":"Hurtukova K et al (2021) Antibacterial properties of a honeycomb-like pattern with cellulose acetate and silver nanoparticles. Materials (Basel). https:\/\/doi.org\/10.3390\/ma14144051","journal-title":"Materials (Basel)"},{"issue":"3","key":"3151_CR40","doi-asserted-by":"publisher","first-page":"103894","DOI":"10.1016\/j.isci.2022.103894","volume":"25","author":"C Xu","year":"2022","unstructured":"Xu C et al (2022) Bactericidal anti-biofilm and anti-virulence activity of vitamin C against carbapenem-resistant hypervirulent Klebsiella pneumoniae. iScience. 25(3):103894. https:\/\/doi.org\/10.1016\/j.isci.2022.103894","journal-title":"iScience."},{"key":"3151_CR41","volume-title":"Clinical microbiology procedures handbook","author":"AL Leber","year":"2016","unstructured":"Leber AL (2016) Synergy testing: broth microdilution checkerboard and broth macrodilution methods. In: Eisenberg IHD (ed) Clinical microbiology procedures handbook, vol 24. American Society for Microbiology press, Washington"},{"issue":"1","key":"3151_CR42","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1093\/toxsci\/kfx069","volume":"158","author":"MO Ogese","year":"2017","unstructured":"Ogese MO et al (2017) Characterization of drug-specific signaling between primary human hepatocytes and immune cells. Toxicol Sci 158(1):76\u201389. https:\/\/doi.org\/10.1093\/toxsci\/kfx069","journal-title":"Toxicol Sci"},{"key":"3151_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells10113019","author":"W Nicolay","year":"2021","unstructured":"Nicolay W et al (2021) Characterization of RNA Sensing Pathways in Hepatoma Cell Lines and Primary Human Hepatocytes. Cells. https:\/\/doi.org\/10.3390\/cells10113019","journal-title":"Cells"},{"issue":"1","key":"3151_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12866-019-1583-7","volume":"19","author":"S Hamed","year":"2019","unstructured":"Hamed S et al (2019) Synergistic action of SPI-1 gene expression in Salmonella enterica serovar typhimurium through transcriptional crosstalk with the flagellar system. BMC Microbiol 19(1):211. https:\/\/doi.org\/10.1186\/s12866-019-1583-7","journal-title":"BMC Microbiol"},{"issue":"12","key":"3151_CR45","doi-asserted-by":"publisher","first-page":"4233","DOI":"10.1128\/JB.00205-08","volume":"190","author":"Y Huang","year":"2008","unstructured":"Huang Y et al (2008) Formate acts as a diffusible signal to induce Salmonella invasion. J Bacteriol 190(12):4233\u20134241. https:\/\/doi.org\/10.1128\/JB.00205-08","journal-title":"J Bacteriol"},{"issue":"1","key":"3151_CR46","doi-asserted-by":"publisher","first-page":"e02170","DOI":"10.1128\/mBio.02170-15","volume":"7","author":"YA Golubeva","year":"2016","unstructured":"Golubeva YA et al (2016) Intestinal long-chain fatty acids act as a direct signal to modulate expression of the salmonella pathogenicity Island 1 Type III secretion system. mbio 7(1):e02170-15. https:\/\/doi.org\/10.1128\/mBio.02170-15","journal-title":"mbio"},{"issue":"1","key":"3151_CR47","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s12866-021-02110-8","volume":"21","author":"S Hamed","year":"2021","unstructured":"Hamed S et al (2021) HilE is required for synergistic activation of SPI-1 gene expression in Salmonella enterica serovar typhimurium. BMC Microbiol 21(1):49. https:\/\/doi.org\/10.1186\/s12866-021-02110-8","journal-title":"BMC Microbiol"},{"key":"3151_CR48","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.bbamem.2019.05.008","volume":"7","author":"M Martinez","year":"1861","unstructured":"Martinez M et al (1861) (2019) Synergistic and antibiofilm activity of the antimicrobial peptide P5 against carbapenem-resistant Pseudomonas aeruginosa. Biochim Biophys Acta Biomembr 7:1329\u20131337. https:\/\/doi.org\/10.1016\/j.bbamem.2019.05.008","journal-title":"Biochim Biophys Acta Biomembr"}],"container-title":["Current Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-03151-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00284-022-03151-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00284-022-03151-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:31:50Z","timestamp":1674865910000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00284-022-03151-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,2]]},"references-count":48,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["3151"],"URL":"https:\/\/doi.org\/10.1007\/s00284-022-03151-6","relation":{},"ISSN":["0343-8651","1432-0991"],"issn-type":[{"value":"0343-8651","type":"print"},{"value":"1432-0991","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,2]]},"assertion":[{"value":"9 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"57"}}